AGPAT2 and Hepatic steatosis: Cortes et al. [10] showed that the alternative monoacylglycerol (MAG) pathway for TG synthesis was activated in the liver of AGPAT2-/- mice, leading to elevated TG levels in the liver, and, ultimately, hepatic steatosis.